Detoxify for IVF: Cutting Everyday Pollutants to Help Infertility
Official title: Endocrine Disrupting Chemical Detox: a Practical Method to Decrease Environmental Exposures and an Evaluation of the Impact on in Vitro Fertilization Treatment
Run by University of Iowa · NCT07802691 · Data updated 2026-11-12
This study tests a guide to help IVF patients reduce everyday environmental pollutants and sees if it lowers chemical exposure in urine, blood, and follicular fluid.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Iowa Academic / other |
| Locations | 1 site (Iowa City, Iowa) |
| Status | Recruiting |
| Started | October 26, 2026 |
| Main results expected | June 30, 2027 |
| Study ends | February 28, 2028 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT07802691 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with unexplained infertility planning IVF, without ovarian reserve or endocrine disorders, and meeting the age and BMI limits who are not using donor gametes.
✕Probably not a fit
Patients with advanced age beyond eligibility, high BMI above 40, smoking or substance use, or significant infertility etiologies may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study provides a guide that explains common sources of environmental toxicants and practical steps to reduce exposure for people undergoing IVF. Researchers will assess understanding of the guide and how well participants maintain the recommended steps over time. They will measure levels of two classes of toxicants in urine, blood, and follicular fluid at baseline, mid-point, and after the intervention to see if exposure decreases in those with unexplained infertility planning IVF. The trial is conducted at the University of Iowa with collaboration from the American Society for Reproductive Medicine, led by Abigail Mancuso.
Why it matters
Potential benefit: If successful, participants may experience lower exposure to harmful environmental chemicals during IVF treatment, potentially supporting reproductive health.
How similar studies have gone: Previous work has explored reducing environmental exposures in reproductive health; this specific guide-based approach in IVF is exploratory and not widely tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: \- Unexplained infertility diagnosis (no identifiable male or female causes to infertility) Exclusion criteria: * Female age 38 years and older * Male age 45 and older * Diagnosis of diminished ovarian reserve * Diagnosis of PCOS/PMOS * Smoking or drug use in either male and/or female partner * BMI \>40 in either partner * Patients using donor oocytes/donor sperm/donor embryos
Where it's running
-
University of Iowa
Iowa City, Iowa, United States Recruiting
Study contacts
- Study coordinator: Abigail Mancuso, MD
- Email: abigail-mancuso@uiowa.edu
- Phone: 319-356-1767
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Differential Granulosa Cell Transcriptome Profiling to Predict Ongoing Pregnancy
Aiming to see if differences in granulosa cell gene activity can predict ongoing pregnancy in IVF and oocyte donation with PGT-A.
-
Carnitine and related supplements before IVF to see if they improve oocytes and embryos
This trial tests whether taking a supplement mix that includes L-carnitine before IVF helps improve the number and quality of eggs and embryos and the chances of pregnancy for women undergoing IVF.
-
Higher or lower starting FSH dose for good-prognosis IVF with PPOS
This trial tests whether starting IVF stimulation with 225 IU or 300 IU of FSH improves oocyte and embryo outcomes in good-prognosis women using PPOS.
-
Environmental and lifestyle factors linked to ART success in infertility patients
This study follows 5,000 infertile men and women to see how environmental exposures and lifestyle relate to the success of assisted reproductive technology.
-
AI tool to analyze sperm and predict their ability to help IVF/ICSI succeed
This project will test an AI platform that analyzes semen samples from men providing sperm for IVF/ICSI to see if it can predict which samples have the best chance of supporting successful IVF/ICSI outcomes.
-
Multiomics study of discarded fresh blastocysts to see patterns linked to chromosomal status
This study tests whether multiomics patterns in discarded 5–6 day blastocysts relate to chromosomal status to better predict embryo viability for IVF patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.